Scientists can now design genetic material called mRNA to help us build immunity to certain viruses, including SARS-CoV-2, ...

The trial of mRNA-1083 met its objectives, stimulating higher immune responses against influenza and SARS-CoV-2 than the licensed flu and COVID vaccines used as comparators in the trial ...